Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SEC61A1 encodes the alpha subunit of the SEC61 complex, a heteromeric protein channel anchored in the ER membrane. The Sec61 channel is the principal route for cotranslational and some posttranslational transport of secretory and transmembrane proteins into the ER, where they fold and mature. SEC61A1 also forms the ribosome receptor and a gated pore in the ER membrane, critical for correct targeting and movement of nascent polypeptides. The protein has ten transmembrane domains that create a central channel capable of dynamic opening and closing for substrate passage. SEC61A1 also controls passive ER Ca²⁺ leakage, contributing to cellular calcium balance and linking it to stress pathways such as the unfolded protein response. Pathogenic mutations in SEC61A1 are associated with genetic kidney diseases and immunodeficiencies, and the target is being explored for anticancer therapy via specific channel inhibitors.
Allosteric inhibition or blockage of the Sec61 channel, preventing protein translocation into the ER; Modulating ER calcium leakage and UPR (unfolded protein response)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein transport protein Sec61 subunit alpha isoform 1 (SEC61A1).